Taxane benefit in breast cancer—a role for grade and chromosomal stability

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

(2013) Miguel Martín et al.   BREAST CANCER RESEARCH AND TREATMENT

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

(2013)   LANCET

Replication stress links structural and numerical cancer chromosomal instability

(2013) Rebecca A. Burrell et al.   NATURE

The CIN4 Chromosomal Instability qPCR Classifier Defines Tumor Aneuploidy and Stratifies Outcome in Grade 2 Breast Cancer

(2013) Attila Marcell Szász et al.   PLoS One

Chromosome instability and deregulated proliferation: an unavoidable duo

(2012) Courtney H. Coschi et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Targeting Karyotypic Complexity and Chromosomal Instability of Cancer Cells

(2012) Anna V. Roschke et al.   CURRENT DRUG TARGETS

Cancer chromosomal instability: therapeutic and diagnostic challenges

(2012) Nicholas McGranahan et al.   EMBO REPORTS

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

(2012) Marco Gerlinger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer

(2011) R. Roylance et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Paradoxical Relationship between Chromosomal Instability and Survival Outcome in Cancer

(2011) N. J. Birkbak et al.   CANCER RESEARCH

Gene expression profiling in breast cancer: classification, prognostication, and prediction

(2011) Jorge S Reis-Filho et al.   LANCET

The 2011 EBCTCG polychemotherapy overview

(2011) Carlo Palmieri et al.   LANCET

Challenges translating breast cancer gene signatures into the clinic

(2011) Britta Weigelt et al.   Nature Reviews Clinical Oncology

Methodological and practical challenges for personalized cancer therapies

(2011) Ignacio I. Wistuba et al.   Nature Reviews Clinical Oncology

Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

(2010) Alexa B. Turke et al.   CANCER CELL

Chromosomal instability: A composite phenotype that influences sensitivity to chemotherapy

(2010) Sarah E. McClelland et al.   CELL CYCLE

Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials

(2010) Nicolai Juul et al.   LANCET ONCOLOGY

Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer

(2009) Frédérique Penault-Llorca et al.   JOURNAL OF CLINICAL ONCOLOGY

Chromosomal instability determines taxane response

(2009) C. Swanton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients

(2008) B. Gazic et al.   CYTOPATHOLOGY

Epothilones and new analogues of the microtubule modulators in taxane-resistant disease

(2008) Michelle Harrison et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis

(2008) A Walther et al.   GUT

The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome

(2008) Jens K. Habermann et al.   INTERNATIONAL JOURNAL OF CANCER

Defining ‘chromosomal instability’

(2008) Jochen B. Geigl et al.   TRENDS IN GENETICS